Postoperative Analgesia and Recovery Quality in Total Thyroidectomy

ConditionPostoperative Pain

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-65

SponsorIstinye University

About this trial

This prospective observational study evaluates the association between postoperative analgesic approaches and recovery outcomes in patients undergoing elective total thyroidectomy. Patients will be followed under routine clinical care without intervention or randomization.

The primary outcome is the Quality of Recovery-15 (QoR-15) score at 24 hours. Secondary outcomes include swallowing pain, resting pain, opioid consumption, postoperative nausea and vomiting, and additional analgesic requirement.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18-75 years

ASA physical status classification I-III

Patients scheduled for elective bilateral total thyroidectomy

Patients undergoing surgery under general anesthesia

Disqualifiers

Chronic opioid use (≥3 months of regular opioid use)

Presence of chronic pain syndrome

Psychiatric illness or cognitive impairment

History of neurological disease (stroke, dementia, Parkinson's disease, etc.)

Trial population

Adults aged 18-75 years with ASA physical status I-III scheduled for elective bilateral total thyroidectomy under general anesthesia. Participants must be cognitively able to read Turkish and complete the QoR-15 questionnaire and provide written informed consent. Patients with chronic opioid use, chronic pain syndromes, psychiatric or neurological disorders, previous cervical surgery, planned extensive surgery, emergency procedures, pregnancy, or expected postoperative ICU need are excluded.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Cervical Plexus Block
Other intervention
Bilateral intermediate cervical plexus block may be performed as part of routine clinical practice based on the attending anesthesiologist's decision. The study is observational, and no intervention, assignment, or protocol-driven procedure is applied. Patients are managed according to standard perioperative care.

Treatment groups

100 Participants

are divided into 2 treatment groups

Group A: Cervical Plexus Block Group0 interventions

Group B: No Block Group1 intervention

Trial outcomes

Primary outcomes

Quality of Recovery-15 (QoR-15) Total Score

Quality of recovery will be assessed using the QoR-15 questionnaire. The total score ranges from 0 to 150, with higher scores indicating better recovery. The outcome will be compared between patients who received cervical plexus block and those who did not.

Time frame

24 hours postoperatively

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Istinye University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: